The project, backed by the Government of Uzbekistan, reinforces Plug Power’s role as a key electrolyzer provider for ...

Approximately 5.1% of Elevation Oncology’s common stock is held by officers, directors, and affiliates who have agreed to tender their shares in support of the merger. The transaction is slated for ...

Investing.com -- Shares of Axsome Therapeutics Inc (NASDAQ: AXSM) fell 1.2% following the U.S. Food and Drug Administration’s (FDA) Refusal to File (RTF) letter regarding the company’s New Drug ...

Dr. Chris Ballance and Dr. Tom Harty, founders of Oxford Ionics, are set to continue their work with IonQ post-acquisition, contributing to quantum technology development in the UK. The combined ...

Investing.com -- Mizuho analysts have downgraded Chewy (NYSE: CHWY) to Neutral, removing its "Top Pick" status, stating that ...

Investing.com -- Goldman Sachs downgraded Mobileye Global (NASDAQ: MBLY) Inc to Neutral from Buy given a weaker-than-expected ...

Belski highlights the notable divergence between overall market performance and the lagging sectors hardest hit by tariff ...

Jefferies analysts maintained a Buy rating on Oracle (NYSE:ORCL) in a note Monday, raising their price target for the stock to $200 from $190 a share.  The firm told investors that it is seeing "more ...

Newsom, a Democrat, requested the Trump administration to withdraw the order to deploy 2,000 National Guard troops, stating that the move was illegal. The Governor accused Trump of creating the ...

Despite short-term concerns such as lower trading volumes, margin balances, and potential Federal Reserve rate cuts, Redburn ...

Citius Pharmaceuticals Inc (NASDAQ: CTXR ), the parent company of Citius Oncology, also saw its shares climb by 6.7%. Meanwhile, Cardinal Health’s stock remained flat after the news.

Shares of Niagen Bioscience Inc (NASDAQ: NAGE) climbed 3.5% after the company announced results from a clinical study published in Aging Cell, which demonstrated ...